Table III.
TGF-β1 | SOX4 | Ezh2 | |||||
---|---|---|---|---|---|---|---|
Groups | N | Breast cancer | Pulmonary nodule | Breast cancer | Pulmonary nodule | Breast cancer | Pulmonary nodule |
Biopsy | 14 | 0.67±0.19b | 1.55±0.54 | 0.85±0.42b | 6.36±4.71 | 0.54±0.23a | 4.33±1.82 |
Non-biopsy | 15 | 0.43±0.06 | 0.64±0.19 | 0.50±0.22 | 2.49±0.91 | 0.39±0.02 | 1.74±0.01 |
t-value | – | 4.70 | 2.77 | 2.80 | 1.40 | 2.41 | 2.47 |
P-value | – | 0.000 | 0.050 | 0.009 | 0.235 | 0.027 | 0.069 |
P<0.05
P<0.01 compared with the non-biopsy group. TGF-β1, transforming growth factor-β1; Ezh2, Enhancer of Zeste homolog 2.